Intra-Cellular Therapies, Inc.

DB:23I Stock Report

Market Cap: €8.6b

Intra-Cellular Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 23I?
Owner TypeNumber of SharesOwnership Percentage
State or Government44,9700.0424%
General Public2,070,1611.95%
Individual Insiders2,236,6242.11%
Institutions101,665,34895.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.


Top Shareholders

Top 25 shareholders own 68.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
FMR LLC
11,116,229€899.7m-1.03%0.06%
9.08%
The Vanguard Group, Inc.
9,628,253€779.3m0.22%0.01%
5.87%
BlackRock, Inc.
6,219,077€503.4m-1.62%0.01%
4.87%
JP Morgan Asset Management
5,165,365€418.1m52.1%0.05%
4.47%
Alafi Capital Company LLC
4,743,770€384.0m0%100.0%
3.63%
Wasatch Advisors LP
3,848,588€311.5m3.51%1.09%
2.88%
Avoro Capital Advisors LLC
3,050,000€246.9m1.67%3.46%
2.8%
Invesco Ltd.
2,965,239€240.0m5.47%0.07%
2.34%
Bellevue Asset Management AG
2,485,627€201.2m0.58%2.48%
1.83%
Norges Bank Investment Management
1,943,730€157.3m0%0.01%
1.75%
State Street Global Advisors, Inc.
1,858,915€150.5m3.14%0.01%
1.63%
ClearBridge Investments, LLC
1,729,729€140.0m0.47%0.1%
1.61%
Geode Capital Management, LLC
1,708,301€138.3m1.31%0.01%
1.53%
Perceptive Advisors LLC
1,622,215€131.3m-5.49%2.96%
1.53%
Pictet Asset Management Limited
1,619,268€131.1m29%0.12%
1.51%
Deep Track Capital, LP
1,600,693€129.6m4.08%4.06%
1.42%
Franklin Resources, Inc.
1,507,506€122.0m8.53%0.04%
1.36%
Suvretta Capital Management, LLC
1,439,026€116.5m-8.11%4.37%
1.32%
GW&K Investment Management, LLC
1,394,196€112.8m0.02%0.93%
1.29%
Holocene Advisors, LP
1,370,831€111.0m-7.36%0.45%
1.14%
AllianceBernstein L.P.
1,208,338€97.8m-11.6%0.03%
1.1%
Marshall Wace LLP
1,160,973€94.0m133%0.14%
1.09%
Westfield Capital Management Company, L.P.
1,159,356€93.8m11.2%0.41%
1.01%
Sharon Mates
1,070,329€86.6m0%no data
0.98%
T. Rowe Price Group, Inc.
1,042,455€84.4m-27%0.01%